Management of primary anorectal mucosal melanoma during the COVID-19 pandemic
We present a case of a 77-year-old Peruvian who was eventually diagnosed with this cancer during the COVID-19 pandemic, which complicated her treatment and allowed the cancer to spread. Her treatment included abdominoperineal resection, bilateral pelvic lymphadenectomy, left internal iliac vein raffia and end colostomy, followed by 3D radiation therapy (50 Gy, 25 sessions) and systemic treatment with nivolumab, all of which were well tolerated. The patient was alive as of 20 August 2023, having survived for more than 3 years since the onset of symptoms.PMID:38414935 | PMC:PMC10898915 | DOI:10.3332/ecancer.2023.1610
Source: Ecancermedicalscience - Category: Cancer & Oncology Authors: Edgar Ferm ín Yan-Quiroz Folker Mija íl Agreda-Castro Lita Diaz-Lozano Richard Tenazoa-Villalobos Lissett Jeanette Fern ández-Rodríguez Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Immunotherapy | Melanoma | Pandemics | Peru Health | Radiation Therapy | Skin Cancer